VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ALNY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HomeStocksALNYInstitutional Holders

ALNY logoAlnylam Pharmaceuticals, Inc. (ALNY) Institutional Ownership

Q2 2026 13F Data|Updated 2026-11-07

✨

Institutional ownership increased this quarter (+2.44 pp), though top 10 holders maintain a highly concentrated 56.3% of institutional value.

Institutional Ownership
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
101.4%$38.5B total value · ▲ +2.44 pp vs prior quarter
Smart Money Score
Based on ownership concentration, fund quality, buying/selling activity, ownership indicators, and institutional trend.
59 / 100
Neutral
Institutions & Flow791 holders-1 net flow (+80 / -81)

AI Insights & Key Takeaways

  • Negative Institutional Flow (-1)
  • Two Sigma Investments, Lp maintains a significant position
  • Top 10 holders control 56.3% of institutional value
  • No Insider Signal

Top Institutional Holders of ALNY

Ranked by reported Q2 2026 13F market value

Top 10 Holders
56.3%
Top 25 Holders
74.2%

Share of total reported institutional value in ALNY held by the largest 10 / 25 filers.

#InstitutionShares HeldMarket ValueQoQ ChangeOwnership %% of Fund
1FMR LLC15.0M$4.52B+3.0%11.253%0.20%
2Capital World Investors11.1M$3.35B+3.2%8.347%0.40%
3BlackRock, Inc.10.9M$3.28B+4.4%8.170%0.05%
4Capital Research Global Investors9.8M$2.94B+2.9%7.303%0.41%
5VANGUARD PORTFOLIO MANAGEMENT LLC6.5M$1.97B+0.7%4.897%0.09%
6VANGUARD CAPITAL MANAGEMENT LLC6.0M$1.82B+1.4%4.516%0.04%
7Invesco Ltd.3.8M$1.13B+34.9%2.812%0.09%
8STATE STREET CORP3.6M$1.07B+7.0%2.663%0.02%
9GEODE CAPITAL MANAGEMENT, LLC2.6M$791.3M-0.9%1.974%0.04%
10JPMORGAN CHASE & CO2.7M$785.3M-57.7%2.004%0.04%
11BAILLIE GIFFORD & CO2.4M$734.5M-2.2%1.827%0.67%
12NORGES BANK2.3M$683.9M—1.702%0.07%
13WELLINGTON MANAGEMENT GROUP LLP2.1M$635.3M+9.0%1.581%0.11%
14Orbis Allan Gray Ltd2.0M$598.3M+48.9%1.489%2.06%
15DODGE & COX2.0M$588.6M+1.4%1.465%0.31%
16TWO SIGMA INVESTMENTS, LP1.9M$564.7M-5.9%1.405%0.41%
17AMERICAN CENTURY COMPANIES INC1.9M$558.1M+2.9%1.389%0.25%
18D. E. Shaw & Co., Inc.1.5M$461.9M+4.1%1.149%0.22%
19Clearbridge Investments, LLC1.3M$379.1M-7.1%0.943%0.31%
20MORGAN STANLEY1.0M$310.7M+2.9%0.773%0.02%
21BANK OF AMERICA CORP /DE/994K$299.4M+2.9%0.745%0.02%
22Legal & General Group Plc925K$278.3M-1.1%0.693%0.06%
23MANUFACTURERS LIFE INSURANCE COMPANY, THE894K$269.1M+34.9%0.669%0.10%
24ROYAL BANK OF CANADA891K$268.2M+12.6%0.667%0.04%
25NORTHERN TRUST CORP887K$267.0M+3.4%0.664%0.03%

denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ALNY — a direct measure of their conviction.

Quarterly Institutional Activity

Filings activity in ALNY during Q2 2026, grouped by how each filer changed its position.

OverviewNew Buyers80Added To187Trimmed501Exited81

New Buyers

80

Institutions that opened a new ALNY position in Q2 2026

  • Deep Track Capital, LP$248.3M
  • Paradigm Biocapital Advisors LP$144.5M
  • Davern Capital Partners, LP$34.0M
  • Longaeva Partners L.P.$33.2M
  • BALYASNY ASSET MANAGEMENT L.P.$28.0M
  • ARROWSTREET CAPITAL, LIMITED PARTNERSHIP$14.9M
  • Alphadyne Asset Management LP$12.2M
  • Catalyst Funds Management Pty Ltd$6.3M
  • KORNITZER CAPITAL MANAGEMENT INC /KS$5.2M
  • TWINBEECH CAPITAL LP$4.3M
  • CenterBook Partners LP$3.7M
  • SIMPLEX TRADING, LLC$3.5M

Exited Positions

81

Institutions that fully closed their ALNY position in Q2 2026

  • PARNASSUS INVESTMENTS, LLC$16.2M
  • FengHe Fund Management Pte. Ltd.$10.8M
  • Varma Mutual Pension Insurance Co$7.0M
  • PUBLIC SECTOR PENSION INVESTMENT BOARD$6.0M
  • SILVERCREST ASSET MANAGEMENT GROUP LLC$3.5M
  • Edgestream Partners, L.P.$1.9M
  • Susquehanna Portfolio Strategies, LLC$1.7M
  • Draper Asset Management, LLC$1.2M
  • DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt

ALNY Institutional Ownership by Quarter

8 quarters of 13F filings · Δ columns show change vs prior quarter

QuarterInst. HoldersΔ HoldersOwnership %Δ OwnershipTotal 13F ValueΔ Value
Q2 2026791+0.5%101.41%+2.44 pp$38.49B6.2%
Q1 20267875.7%98.97%1.01 pp$41.04B19%
Q4 2025835+4.0%99.98%1.03 pp$50.66B12%
Q3 2025803+25%101.01%1.44 pp$57.86B+43%
Q2 2025643+7.3%102.45%+3.40 pp$40.41B+28%
Q1 2025599+5.3%99.05%1.46 pp$31.66B+13%
Q4 2024569+5.6%100.51%+4.02 pp$27.91B11%
Q3 2024539—96.49%—$31.48B—

Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.

ALNY — Frequently Asked Questions

Quick answers to the most common questions about buying ALNY stock.

What percentage of ALNY is owned by institutions?

Based on Q2 2026 13F filings, institutional ownership of Alnylam Pharmaceuticals, Inc. stands at 101.4%, held across 791 reporting institutions.

Who is the largest institutional holder of ALNY?

FMR LLC is the largest reported institutional holder of ALNY, with approximately 15,023,962 shares worth $4.52B as of Q2 2026.

Is ALNY a hedge fund favorite?

Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of ALNY, including TWO SIGMA INVESTMENTS, LP.

What is ALNY's Smart Money Score?

Our composite Smart Money Score for ALNY is 59 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought ALNY this quarter?

80 institutions opened new positions in ALNY during Q2 2026, while 81 fully exited. 187 added to existing positions and 501 trimmed.

How is institutional ownership of ALNY changing?

ALNY institutional ownership rose by 2.44 percentage points quarter-over-quarter, with a net change of +4 holders.

How concentrated is ALNY ownership among the top holders?

The top 10 institutions account for 56.3% of all reported 13F value in ALNY, and the top 25 account for 74.2%.

Where does this ALNY institutional ownership data come from?

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.

$1.2M
  • SANDERS MORRIS HARRIS LLC$1.0M
  • Private Advisory Group LLC$903K
  • Elm Partners Management LLC$676K
  • ALNYAlnylam Pharmaceuticals, Inc.
    $155.94$20.8B
    Overview & Tools
    OverviewChart Terminal ↗Visualize
    Valuation & Forecasts
    Valuation ModelsEstimatesDCF Model
    Price & Analyst Data
    Analyst TargetsPrice History
    Financial Statements
    Income StatementBalance SheetCash FlowRatios & Margins
    Performance
    P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
    Discovery & Screens
    Live BreakoutsStock ScreenerOwnership